Dr. Robin L. Obenchain

Dr. Ortiz Cruz joined Ironwood Cancer & Research Center in September 2014, after completing her hematology and medical oncology fellowship at the University of South Carolina in Charleston. She completed two years of research at the National Cancer Institute | National Institutes of Health in Bethesda Maryland where she was involved with clinical research in radiation oncology in addition to work with medical oncology. Dr. Ortiz Cruz also completed an internal medicineresidency training program at Banner Good Samaritan Medical Center in Phoenix. She has published several articles in scientific journals and presented at various meetings. Dr. Cruz's specializes in solid tumor and hematologic disorders with a special interest in breast, colon cancer and lymphoma. Dr. Cruz's goal is to deliver the best care available for her patients by providing personalized treatment planning in conjunction with cutting-edge therapy.Dr. Cruz's personal goal is to deliver the best care available for her patients with the understanding that personalized treatment planning in conjunction with utilizing cutting-edge therapy is the best means to achieve this goal. Dr. Cruz is rated as a Distinguished provider by MediFind in the treatment of Agranulocytosis. Her top areas of expertise are Breast Cancer, Severe Congenital Neutropenia, Paget Disease of the Breast, and Agranulocytosis.

Dr. Kalmadi joined Ironwood Cancer and Research Centers in 2008 and serves as Chief Medical Officer.  After finishing his medical schooling in India, Dr. Sujith Kalmadi completed his residency training and fellowship at the Cleveland Clinic in Cleveland, Ohio. He then served as academic clinical faculty at the Cleveland Clinic School of Medicine (Lerner School) in Cleveland, Ohio and subsequently at Baylor College of Medicine in Houston, Texas. During his tenure at these prestigious institutions, he pioneered several novel clinical research trials which have been lauded at national scientific meetings and published in peer reviewed journals. His areas of clinical and research interests include several solid tumors and hematological disorders. He currently resides in Chandler with his wife and three children, and enjoys tennis, chess and racquetball during his spare time. He is board certified in Internal Medicine, Hematology and Medical Oncology. Dr. Kalmadi is rated as a Distinguished provider by MediFind in the treatment of Agranulocytosis. His top areas of expertise are Lung Cancer, Familial Colorectal Cancer, Colorectal Cancer, and Severe Congenital Neutropenia.

Dr. Neel Dharia joined Ironwood Cancer & Research Centers in January 2012. Dr. Dharia received his medical degree from Mumbai University, Mahatma Gandhi Missions Medical College in 1999. His residency was completed in Internal Medicine at McLaren Regional Medical Center and Michigan State University College of Human Medicine in Flint, Michigan. Dr. Dharia was a hospitalist at several Phoenix Valley hospitals between 2003-2007 and completed a fellowship in Hematology/Oncology at St. Elizabeth's Medical Center (affiliated with Tufts University School of Medicine) in Boston, Massachusetts from 2007-2010. He came back to Arizona in 2010 and is board-certified in medical oncology. Dr. Dharia's areas of interest include GI malignancies, melanoma, breast and lung cancers.You can find that team at Ironwood Cancer & Research Centers. With community-based centers strategically located throughout the Metro Phoenix area, Ironwood offers advanced therapies and a multi-disciplinary approach usually associated with large academic centers – but with a personalized touch recognizing the individual needs of the patient.Studies have shown the importance of a multi-disciplinary approach in effectively treating cancer. We spare you time and worry simply by having all the doctors, therapists, and resources you need in one convenient location, eliminating the delays and miscommunication. These collaborative efforts ensure the highest standards of care. Because Ironwood is actively involved in cutting-edge research, you can also benefit from promising new treatments through participation in clinical trials.  At Ironwood Cancer & Research Centers we evaluate you and develop a personalized treatment plan specifically for you to insure the best possible outcome. Dr. Dharia is rated as a Distinguished provider by MediFind in the treatment of Agranulocytosis. His top areas of expertise are Familial Colorectal Cancer, Breast Cancer, Lynch Syndrome, and Colorectal Cancer.